Abstract
Interleukin (IL)-18, an important mediator of innate and adaptive immunity, plays multiple roles in chronic inflammation, in autoimmune diseases, in a variety of cancers and in number of infectious diseases. IL-18 promoter polymorphisms have been also noted associated with various inflammatory diseases. We investigated the association of IL-18 promoter polymorphisms (−656T/G, −607A/C and −137C/G) with systemic lupus erythematosus (SLE) in Taiwan Chinese patients and controls. Six haplotypes (hts) were identified from the three promoter polymorphisms. The genotype distribution of the ht1 (GCC), ht2 (TAC), ht4 (GAC) and ht5 (TCC) were different in patients and controls (P<0.002). Moreover, the haplotype and genotype frequencies of ht1 were significantly increased in patients with discoid rash (P=0.045, odds ratio (OR): 2.01, 95% confidence interval (CI): 1.01–4.00; P=0.027, OR: 5.13, 95% CI: 1.41–18.68). In addition, the homozygous genotype ht1/ht1 was significant increased in patients with serositis (P=0.015, OR: 9.78, 95% CI: 1.55–61.73). These observations suggest that the three promoter polymorphisms contribute to the genetic background of SLE pathogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kotzin BL . Systemic lupus erythematosus. Cell 1996; 85: 303–306.
Nath SK, Kilpatrick J, Harley JB . Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004; 16: 794–800.
Wu MC, Huang CM, Tsai JJ, Chen HY, Tsai FJ . Polymorphisms of the interleukin-4 gene in chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003; 12: 21–25.
Robak E, Sysa-Jedrzejowska A, Robak T, Smolewski P . Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol 2006; 25: 225–233.
Chen JY, Wang CM, Ma CC, Chow YH, Luo SF . The −844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. Genes Immun 2005; 6: 123–128.
al-Janadi M, Raziuddin S . B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 1993; 20: 1885–1891.
al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S . Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58–67.
Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I . Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000; 18: 565–570.
Sun KH, Yu CL, Tang SJ, Sun GH . Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 2000; 99: 352–360.
de Faucal P, Godard A, Peyrat MA, Moreau JF, Soulillou JP . Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus. Ann Immunol (Paris) 1984; 135D: 161–172.
Wong CK, Ho CY, Li EK, Lam CW . Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589–593.
Wong CK, Li EK, Ho CY, Lam CW . Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 1078–1081.
Amerio P, Frezzolini A, Abeni D, Teofoli P, Girardelli CR, De Pita O et al. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol 2002; 20: 535–538.
Robak E, Robak T, Wozniacka A, Zak-Prelich M, Sysa-Jedrzejowska A, Stepien H . Proinflammatory interferon-gamma-inducing monokines (interleukin-12, interleukin-18, interleukin-15) – serum profile in patients with systemic lupus erythematosus. Eur Cytokine Netw 2002; 13: 364–368.
Aringer M, Smolen JS . Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004; 13: 344–347.
Calvani N, Richards HB, Tucci M, Pannarale G, Silvestris F . Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clin Exp Immunol 2004; 138: 171–178.
Gillespie MT, Horwood NJ . Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev 1998; 9: 109–116.
Gracie JA, Robertson SE, McInnes IB . Interleukin-18. J Leukoc Biol 2003; 73: 213–224.
Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1393–1401.
Tone M, Thompson SA, Tone Y, Fairchild PJ, Waldmann H . Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol 1997; 159: 6156–6163.
Marshall JD, Aste-Amezaga M, Chehimi SS, Murphy M, Olsen H, Trinchieri G . Regulation of human IL-18 mRNA expression. Clin Immunol 1999; 90: 15–21.
Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 2002; 3: 394–399.
Giedraitis V, He B, Huang WX, Hillert J . Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146–152.
Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, Ogata A et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun 2006; 342: 1413–1416.
Nieters A, Linseisen J, Becker N . Association of polymorphisms in Th1, Th2 cytokine genes with hayfever and atopy in a subsample of EPIC-Heidelberg. Clin Exp Allergy 2004; 34: 346–353.
Shin HD, Kim LH, Park BL, Choi YH, Park HS, Hong SJ et al. Association of interleukin 18 (IL18) polymorphisms with specific IgE levels to mite allergens among asthmatic patients. Allergy 2005; 60: 900–906.
Kruse S, Kuehr J, Moseler M, Kopp MV, Kurz T, Deichmann KA et al. Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003; 111: 117–122.
Pawlik A, Kurzawski M, Czerny B, Gawronska-Szklarz B, Drozdzik M, Herczynska M . Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens 2006; 67: 415–418.
Germer S, Higuchi R . Single-tube genotyping without oligonucleotide probes. Genome Res 1999; 9: 72–78.
Hamann L, Hamprecht A, Gomma A, Schumann RR . Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes. J Immunol Methods 2004; 285: 281–291.
Linker-Israeli M, Wallace DJ, Prehn J, Michael D, Honda M, Taylor KD et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun 1999; 1: 45–52.
Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL . Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 2004; 5: 484–492.
Mok CC, Lanchbury JS, Chan DW, Lau CS . Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090–1095.
Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA . A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997; 40: 2207–2211.
Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J . Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2001; 2: 363–366.
Tanaka Y, Nakashima H, Hisano C, Kohsaka T, Nemoto Y, Niiro H et al. Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenetics 1999; 49: 266–271.
Nakashima H, Inoue H, Akahoshi M, Tanaka Y, Yamaoka K, Ogami E et al. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 1999; 453: 187–190.
Esfandiari E, McInnes IB, Lindop G, Huang FP, Field M, Komai-Koma M et al. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol 2001; 167: 5338–5347.
Smolen JS, Steiner G, Aringer M . Anti-cytokine therapy in systemic lupus erythematosus. Lupus 2005; 14: 189–191.
Haus-Seuffert P, Meisterernst M . Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. Mol Cell Biochem 2000; 212: 5–9.
Dailey L, Roberts SB, Heintz N . Purification of the human histone H4 gene-specific transcription factors H4TF-1 and H4TF-2. Genes Dev 1988; 2: 1700–1712.
Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M, Puchalski Z et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002; 51: 3347–3349.
Sivalingam SP, Yoon KH, Koh DR, Fong KY . Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 2003; 62: 498–504.
Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A et al. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun 2005; 6: 211–216.
Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
Stephens M, Donnelly P . A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162–1169.
Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.
Acknowledgements
This work was supported by China Medical University (CMU95-142), China Medical University Hospital (DMR-91-003) and National Science Council in Taiwan (NSC95-2314-B-039-035).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Genes and Immunity website (http://www.nature.com/gene)
Rights and permissions
About this article
Cite this article
Lin, YJ., Wan, L., Lee, CC. et al. Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients. Genes Immun 8, 302–307 (2007). https://doi.org/10.1038/sj.gene.6364387
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364387
Keywords
This article is cited by
-
Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment
American Journal of Clinical Dermatology (2016)
-
Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case–control study
Cancer Cell International (2015)
-
Ethnicity-stratified analysis of the association between IL-18 polymorphisms and systemic lupus erythematosus in a European population: a meta-analysis
Archives of Dermatological Research (2015)
-
Association of interleukin-18 and systemic lupus erythematosus
Rheumatology International (2013)
-
Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis
Molecular Biology Reports (2013)